[1] |
Selway JL, Kurczab T, Kealey T, et al. Toll⁃like receptor 2 acti⁃vation and comedogenesis: implications for the pathogenesis of acne[J]. BMC Dermatol, 2013,13:10. doi: 10.1186/1471⁃5945⁃13⁃10.
|
[2] |
On SC, Zeichner J. Isotretinoin updates[J]. Dermatol Ther, 2013,26(5):377⁃389. doi: 10.1111/dth.12084.
|
[3] |
Fathy A, Mohamed RW, Ismael NA, et al. Expression of toll⁃like receptor 2 on peripheral blood monocytes of patients with inflammatory and noninflammatory acne vulgaris[J]. Egypt J Immunol, 2009,16(1):127⁃134.
|
[4] |
Kim J. Review of the innate immune response in acne vulgaris: activation of toll⁃like receptor 2 in acne triggers inflammatory cytokine responses[J]. Dermatology, 2005,211(3):193⁃198. doi: 10.1159/000087011.
|
[5] |
Park AJ, Agak GW, Qin M, et al. G2A attenuates Propionibac⁃terium acnes induction of inflammatory cytokines in human monocytes[J]. Ann Dermatol, 2017,29(6):688⁃698. doi: 10.5021/ ad.2017.29.6.688.
|
[6] |
Hou XX, Chen G, Hossini AM, et al. Aryl hydrocarbon receptor modulates the of TNF⁃α and IL⁃8 in human sebocytes via the MyD88⁃p65NF⁃κBp38MAPK signaling pathways[J]. J Innate Immun, 2019,11(1):41⁃51. doi: 10.1159/000491029.
|
[7] |
Tsukada M, Schröder M, Roos TC, et al. 13⁃cis Retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all⁃trans retinoic acid and binding to retinoid acid receptors[J]. J Invest Dermatol, 2000,115(2):321⁃327. doi: 10.1046/j.1523⁃1747.2000.00066.x.
|
[8] |
Takeuchi O, Akira S. Pattern recognition receptors and inflam⁃mation[J]. Cell, 2010,140(6):805⁃820. doi: 10.1016/j.cell.2010. 01.022.
|
[9] |
Jung MK, Ha S, Son JA, et al. Polyphenon⁃60 displays a therapeutic effect on acne by suppression of TLR2 and IL⁃8 via down⁃regulating the ERK12 pathway[J]. Arch Dermatol Res, 2012,304(8):655⁃663. doi: 10.1007/s00403⁃012⁃1249⁃x.
|
[10] |
Oliveira⁃Nascimento L, Massari P, Wetzler LM. The role of tlr2 in infection and immunity[J]. Front Immunol, 2012,3:79. doi: 10.3389/fimmu.2012.00079.
|
[11] |
Papakonstantinou E, Aletras AJ, Glass E, et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin[J]. J Invest Dermatol, 2005,125(4):673⁃684. doi: 10.1111/j.0022⁃202X.2005. 23848.x.
|
[12] |
Sardana K, Verma G. Propionibacterium acnes and the Th1Th17 axis, implications in acne pathogenesis and treatment[J]. Indian J Dermatol, 2017,62(4):392⁃394. doi: 10.4103/ijd.IJD_483_16.
|
[13] |
Dispenza MC, Wolpert EB, Gilliland KL, et al. Systemic isotretinoin therapy normalizes exaggerated TLR⁃2⁃mediated innate immune responses in acne patients[J]. J Invest Dermatol, 2012,132(9):2198⁃2205. doi: 10.1038/jid.2012.111.
|
[14] |
Guruvayoorappan C, Kuttan G. 13 cis⁃retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation[J]. J Exp Ther Oncol, 2008,7(3):173⁃182.
|
[15] |
Andela VB, Rosier RN. The proteosome inhibitor MG132 attenuates retinoic acid receptor trans⁃activation and enhancestrans⁃repression of nuclear factor kappaB. Potential relevance to chemo⁃preventive interventionswith retinoids[J]. Mol Cancer, 2004,3:8.
|
[16] |
Karkeni E, Bonnet L, Astier J, et al. All⁃trans⁃retinoic acid represses chemokine in adipocytes and adipose tissue by inhibiting NF⁃κB signaling[J]. J Nutr Biochem, 2017,42:101⁃107. doi: 10.1016/j.jnutbio.2017.01.004.
|
[17] |
Zeng Z, Sun Z, Huang M, et al. Nitrostyrene derivatives act as RXRα ligands to inhibit TNFα activation of NF⁃κB[J]. Cancer Res, 2015,75(10):2049⁃2060. doi: 10.1158/0008⁃5472.CAN⁃14⁃2435
|
[18] |
Sulaiman G, Cooke A, Ffrench B, et al. MyD88 is an essential component of retinoic acid⁃induced differentiation in human pluripotent embryonal carcinoma cells[J]. Cell Death Differ, 2017,24(11):1975⁃1986. doi: 10.1038/cdd.2017.124
|
[19] |
Li Y, Gao Y, Cui T, et al. Retinoic acid facilitates Toll⁃like receptor 4 to improve intestinal barrier function through retinoic acid receptor beta[J]. Cell Physiol Biochem, 2017,42(4):1390⁃1406. doi: 10.1159/000479203.
|